Ophthotech
New York, US · Delaware corporation · 4 known investors
Find your way into Ophthotech
134 people in our graph share verified history with the Ophthotech team — schools, employers, funds. One of them is your warm intro.
Catherine Pearce, DHSc, MBAunlockedknows Mike Atieh · together at Merck (overlapped)
×7knows the team · via Merck
×4knows the team · via Chubb
Founders & leadership
DG
David GuyerFounder
GS
Glenn SblendorioExecutive
MA
Mike AtiehinExecutive Vice President, Chief Financial and Business Officer2014–2016Mike Atieh was Executive Vice President and Chief Financial and Business Officer at Ophthotech through 2016, and previously held CFO positions at OSI Pharmaceuticals and Eyetech, which was acquired by Valeant Pharmaceuticals in 2012. Earlier in his career, he spent 20 years at Merck in executive roles spanning human health, managed care, government relations, and treasury, and began his career as an audit manager at Arthur Young.
DR
David RedlickNamed on SEC filing
KW
Keith WestbyNamed on SEC filing
DC
David CarrollNamed on SEC filing
TD
Thomas DyrbergNamed on SEC filing
AB
Axel BolteNamed on SEC filing
JP
Jane Pritchett HendersonNamed on SEC filing
Board
MR
Investors · 4
Reported raises · per SEC filings
Form D private placements$11.4M disclosed across 1 round · 2018
▶$11.4MraisedNov 2018 · 2 investors · BiotechnologyRule 506(b)
▶$11.4MraisedNov 2018 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David RedlickDirector
- Michael RossDirector
- Keith WestbyExecutive Officer
- David CarrollExecutive Officer
- Thomas DyrbergDirector
- Glenn SblendorioExecutive Officer, Director
- Axel BolteDirector
- Jane Pritchett HendersonDirector
- David GuyerExecutive Officer, Director
- Offering amount
- $11.7M
- Amount sold
- $11.4M
- First sale
- Oct 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Vedantu8 shared keywordsVedantu is an online learning platform that provides free chapter-wise NCERT solutions and study materials for Class 12 CBSE students across Science, Commerce, and Arts subjects. It also offers resources for competitive exam preparation such as JEE and NEET, aligned with the latest CBSE syllabus.
Thumbnail for Seragon Pharmaceuticals7 shared keywordsGenentech is a biotechnology company that develops and manufactures breakthrough medicines in the United States, backed by a $50 billion commitment to U.S. manufacturing and scientific innovation.
Companies competing with Ophthotech for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- Who founded Ophthotech?
- Ophthotech was founded by David Guyer.
- Who are Ophthotech's investors?
- Ophthotech's investors include Sofinnova Ventures, SV Health Investors, Clarus, SV Life Sciences.
- How much funding has Ophthotech raised?
- Ophthotech has disclosed $11.4M raised across 1 round.
- Where is Ophthotech headquartered?
- Ophthotech is headquartered in New York, US.